hVIVO, a U.K.-based provider of human disease models, and Everbridge, a global provider of SaaS-based unified critical communications solutions, are joining forces to offer a next-generation, virtual clinical trial platform that has the potential to transform the trial volunteer experience.

The offering leverages secure clinical collaboration and telemedicine solutions from Everbridge to transition the trial volunteer experience from a sporadic notification process to an interactive, self-service community-based environment. The partnership provides access to personalized communications, secure dialog and remote data sharing between volunteers and their clinicians, which can help to streamline clinical trials and improve operational efficiencies.

The novel, Web-based clinical trial and volunteer communication platform will aid in maximizing the engagement, retention and growth of volunteers enrolled for clinical trials through continuous 360 degree information collection and exchange via secure mobile and video communications. The platform promotes an ongoing dialog with volunteers, stimulating volunteer recruitment and avoiding trial delays.

The partnership between hVIVO and Everbridge will promote: effective communication with the 100,000-person volunteer community; secure communication and collaboration between clinicians and volunteers; remote virtual health and telemedicine visits and data capture for volunteers and hVIVO’s clinical studies customers; and better volunteer recruitment and clinical workflow efficiencies

hVIVO and Everbridge plan to roll out the virtual clinical trial platform in phases, starting with the initial Volunteer Communication Platform in early 2016, followed by the full technology suite later in the year.